Encodia
Fei Huang, also known as Phil, has a background in organic synthesis and small-molecule therapies. With a Master's degree from Northern Arizona University and a Bachelor's degree from Nanjing University, Fei has worked as a Scientist at Encodia, Inc. focusing on reagent development for protein analysis. Prior to that, Fei held positions at PharmAkea Therapeutics, where Fei (Phil) worked on therapies for fibrotic diseases, Alere Inc., specializing in in vitro diagnostics product development, and Nanosyn, where Fei (Phil) focused on organic synthesis.
Encodia
4 followers
Encodia is a privately held biotechnology company bringing the power of sequencing to proteomics. The company's patented ProteoCode technology enables highly scalable protein analysis via an accessible and easy-to-use benchtop instrument. Tools employing Encodia’s ProteoCode technology will drive new biological understanding with impact in data-driven drug discovery and development, new high complexity diagnostics, and beyond.